BIOMAT Database Logo BIOMAT Database Logo

[Use of a new hemostatic preparation kaprofer in therapeutic endoscopy]. 1995

O N Skriabin, and A P Karitskiĭ

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004724 Endoscopy Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body. Endoscopic Surgical Procedures,Surgical Procedures, Endoscopic,Endoscopic Surgical Procedure,Endoscopy, Surgical,Surgical Endoscopy,Surgical Procedure, Endoscopic,Procedure, Endoscopic Surgical,Procedures, Endoscopic Surgical
D005290 Ferric Compounds Inorganic or organic compounds containing trivalent iron. Compounds, Ferric
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015119 Aminocaproic Acid An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. 6-Aminocaproic Acid,6-Aminohexanoic Acid,epsilon-Aminocaproic Acid,Amicar,CY-116,Capralense,Capramol,Caproamin,Caprocid,Caprolest,Epsamon,Epsikapron,Hemocaprol,Hexalense,6 Aminocaproic Acid,6 Aminohexanoic Acid,CY 116,CY116,epsilon Aminocaproic Acid

Related Publications

O N Skriabin, and A P Karitskiĭ
[The use of the hemostatic preparation Kaprofer in emergency surgery].
January 1995, Vestnik khirurgii imeni I. I. Grekova,
O N Skriabin, and A P Karitskiĭ
[Dynamic changes in the healing of liver wounds while using the new hemostatic preparation kaprofer].
January 1994, Klinicheskaia khirurgiia,
O N Skriabin, and A P Karitskiĭ
[Experience in the use of the local hemostatic agent Kaprofer in otorhinolaryngologic practice].
January 1987, Vestnik otorinolaringologii,
O N Skriabin, and A P Karitskiĭ
New topical hemostatic powders in endoscopy.
November 2013, Gastroenterology & hepatology,
O N Skriabin, and A P Karitskiĭ
[Therapeutic use of a new hemostatic; clinical experiences with 5-hydroxytriptamine].
January 1955, Bollettino - Societa medico chirurgica Cremona,
O N Skriabin, and A P Karitskiĭ
[Toxicological characteristics of a new hemostatic preparation].
January 1979, Zhurnal eksperimental'noi i klinicheskoi meditsiny,
O N Skriabin, and A P Karitskiĭ
[A new hepatic therapeutic preparation. Its use in pediatrics].
October 1971, Minerva pediatrica,
O N Skriabin, and A P Karitskiĭ
[A new bismuth-carbon preparation for therapeutic use].
November 1953, Deutsches medizinisches Journal,
O N Skriabin, and A P Karitskiĭ
[Clinical use of a new hemostatic].
June 1950, Rivista di ostetricia e ginecologia,
O N Skriabin, and A P Karitskiĭ
[Clinical use of thrombin preparation as a local hemostatic].
February 1983, Shikai tenbo = Dental outlook,
Copied contents to your clipboard!